Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2025-12-26 @ 2:07 AM
Study NCT ID:
NCT01108705
Status:
TERMINATED
Last Update Posted:
2015-10-12
First Post:
2010-04-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05
Start Date Type:
None
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-15
First Submit QC Date:
None
Study First Post Date:
2010-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-10-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-09-23
Last Update Post Date:
2015-10-12
Last Update Post Date Type:
ESTIMATED